Radiopharm Theranostics Limited (ASX:RAD)
Australia · Delayed Price · Currency is AUD 0.0210
+0.0010 (5.00%)
Apr 20, 2026, 3:40 PM AEST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of 74.43 million as of April 20, 2026. Its market cap has increased by 27.56% in one year.
Market Cap
74.43M
Enterprise Value
38.07M
Revenue
16.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from 101.33M to 74.43M, a decrease of -26.55%. That is a compound annual growth rate of -6.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 74.43M | -16.00% |
| Dec 31, 2025 | 88.61M | 68.31% |
| Dec 31, 2024 | 52.65M | 91.43% |
| Dec 29, 2023 | 27.50M | -20.28% |
| Dec 30, 2022 | 34.50M | -65.53% |
| Dec 31, 2021 | 100.07M | -1.25% |
| Nov 25, 2021 | 101.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 106.41M |
| Immutep | 101.69M |
| Paradigm Biopharmaceuticals | 101.65M |
| Arovella Therapeutics | 97.91M |
| Botanix Pharmaceuticals | 97.57M |
| Cynata Therapeutics | 85.48M |
| Amplia Therapeutics | 84.66M |
| LTR Pharma | 72.71M |